Skip to content
2000
Volume 8, Issue 1
  • ISSN: 2452-2716
  • E-ISSN: 2452-2724

Abstract

Introduction/Background

BCL is a BCS Class III drug. It has a relatively low oral bioavailability of about 40% due to its short half-life (2-4 hours) and rapid clearance from the body. Developing gastroretentive technology can enhance its bioavailability by prolonging its retention in the stomach, ensuring more consistent absorption and therapeutic effects. It is well absorbed in the acidic environment of the stomach (pH 1-4). Due to the highly hydrophilic nature of BCL, the development of hydrocolloid-based floating beads for oral controlled release presents a significant challenge. To overcome this challenge, a blend of Sodium Alginate and Gelucire 43/01 was used which forms an intercalating structure network that helps in controlling drug release in the stomach.

Aim

The aim of this study is to develop and optimize a gastro buoyant drug delivery system of Baclofen (BCL) using a Taguchi 32-factorial design assisted formulation. The formulation encompasses Gelucire 43/01 and sodium alginate to create gastro-buoyant multi-unit systems that provide controlled drug release in the gastric environment.

Objective

To develop and characterize BCL loaded beads matrixed with Gelucire 43/01 and Sodium Alginate to retain in the stomach for achieving site-specific drug delivery. The formulation were investigated to achieve a controlled release of BCL to maintain therapeutic drug level concentration over an extended period, reducing the frequency of dosing. Utilization of 32 factorial designs to investigate the effects of various formulation variables on the buoyancy time (Y) and drug release (Y) profile..

Methodology

09 formulations were prepared as per 32 Taguchi factorial design studies using Minitab software.

Results and Discussion

From conducted optimization studies, it was found that Gelucire 43/01 is responsible for achieving buoyancy and retardation of Baclofen from the intercalating polymeric matrices in 0.1 N HCl. Drug excipient thermal analysis studies confirmed that there is development of polyelectrolyte complex. All the formulations remained buoyant till the time of drug release with 100% buoyancy. Entrapment efficiency ranges from 99.74-90.90 with a low standard deviation. The obtained polynomial quadratic equation indicates the synergistic effect for both the polymers for Y and Y response. % dissolution efficiency ranging from 92.78 to 99.62, which means formulations have potential to produce therapeutic response when given . By using topography studies using SEM, it was found that there is a generation of porous structure which leads to lesser density than the utility (1.04 g/cm3) and is responsible for achieving buoyancy. Formulations F2 and F3 were found to be optimized. Drug release kinetics suggested that all the formulations follow zero-order kinetics with low AIC values. Obtained Durbin-Watson statistics suggested that models are highly validated and the degree of error is less for both responses (Y and Y).

Conclusion

It may be concluded that polymer matrices composed of Gelucire 43/01 and sodium alginate as release retardants may be an excellent carrier for stomach-specific delivery of model drug BCL.

Loading

Article metrics loading...

/content/journals/caps/10.2174/0124522716362601250212100844
2025-03-13
2025-09-28
Loading full text...

Full text loading...

References

  1. LiJ. WuH. JiangK. LiuY. YangL. ParkH.J. Alginate calcium microbeads containing chitosan nanoparticles for controlled insulin release.Appl. Biochem. Biotechnol.2021193246347810.1007/s12010‑020‑03420‑933026616
    [Google Scholar]
  2. SatishbabuB.K. RaviR.B. SandeepV.R. ShrutinagR. Formulation and evaluation of floating drug delivery system of famotidine.Indian J. Pharm. Sci.201072673874410.4103/0250‑474X.8458321969746
    [Google Scholar]
  3. HuanbuttaK. NernplodT. AkkaramongkolpornP. SriamornsakP. Design of porous Eudragit ® L beads for floating drug delivery by wax removal technique.Asian J Pharm Sci201712322723410.1016/j.ajps.2016.12.00232104334
    [Google Scholar]
  4. ShimpiS. ChauhanB. MahadikK.R. ParadkarA. Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation.AAPS PharmSciTech200453515610.1208/pt05034315760076
    [Google Scholar]
  5. PanigrahiK.C. PatraC.N. JenaG.K. Gelucire: A versatile polymer for modified release drug delivery system.Future J Pharm Sci20184110210810.1016/j.fjps.2017.11.001
    [Google Scholar]
  6. MishraR. DholeS. Lipid-based floating multiparticulate delivery system for bioavailability enhancement of berberine hydrochloride.J. Appl. Pharm. Sci.2019911364710.7324/JAPS.2019.91105
    [Google Scholar]
  7. MaZ. WangN. HeH. TangX. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.J. Control. Release201931635938010.1016/j.jconrel.2019.10.05331682912
    [Google Scholar]
  8. WuT. ZivanovicS. DraughonF.A. ConwayW.S. SamsC.E. Physicochemical properties and bioactivity of fungal chitin and chitosan.J. Agric. Food Chem.200553103888389410.1021/jf048202s15884813
    [Google Scholar]
  9. AroraS. AliJ. AhujaA. KharR.K. BabootaS. Floating drug delivery systems: A review.AAPS PharmSciTech200563E372E39010.1208/pt06034716353995
    [Google Scholar]
  10. DeyN.S. MajumdarS. RaoM.E.B. Multiparticulate drug delivery systems for controlled release.Trop. J. Pharm. Res.20087310.4314/tjpr.v7i3.14692
    [Google Scholar]
  11. GaurP.K. MishraS. KumarA. PandaB.P. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box–Behnken design.Artif. Cells Nanomed. Biotechnol.201442316717710.3109/21691401.2013.80008123763514
    [Google Scholar]
  12. OladiranG.S. BatchelorH.K. Determination of ibuprofen solubility in wax: A comparison of microscopic, thermal and release rate techniques.Eur. J. Pharm. Biopharm.200767110611110.1016/j.ejpb.2007.01.00917321730
    [Google Scholar]
  13. GhartiK.P. BudhathokiU. ThapaP. BhargavaA. Formulation in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug.J. Young Pharm.20124420120810.4103/0975‑1483.10436323493037
    [Google Scholar]
  14. JagdaleS.C. AgavekarA.J. PandyaS.V. KuchekarB.S. ChabukswarA.R. Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride.AAPS PharmSciTech20091031071107910.1208/s12249‑009‑9300‑819672719
    [Google Scholar]
  15. IshakR.A.H. Buoyancy-generating agents for stomach-specific drug delivery: An overview with special emphasis on floating behavior.J. Pharm. Pharm. Sci.20151817710010.18433/J3602K25877444
    [Google Scholar]
  16. SiepmannF. MuschertS. FlamentM. LetermeP. GayotA. SiepmannJ. Controlled drug release from Gelucire-based matrix pellets: Experiment and theory.Int. J. Pharm.2006317213614310.1016/j.ijpharm.2006.03.00616621362
    [Google Scholar]
  17. O’neilMJ The merck indexAn encyclopedia of chemicals, drugs, and biologicals200174(5)33910.1002/ddr.21085
    [Google Scholar]
  18. AbdelkaderH. AbdallaO.Y. SalemH. Formulation of controlled-release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation.AAPS PharmSciTech20078415610.1208/pt080410018181521
    [Google Scholar]
  19. SoniS. RamV. VermaA. 32 Factorial design assisted crushed puffed rice-HPMC-chitosan based hydrodynamically balanced system of metoprolol succinate.Drug Deliv. Lett.202010323724910.2174/2210303110999200408122629
    [Google Scholar]
  20. SoniS. BahugunaD. Design, development, and in vitro evaluation of single unit hydrodynamically balanced system of Captopril.Curr Ind Sci20231e08082321953010.2174/2210299X01666230808152133
    [Google Scholar]
  21. MogantiM NanjappaSH Formulation and optimization of gastroretentive bilayer tablets of calcium carbonate using D-optimal mixture design.e-Polymers20212110577110.1515/epoly‑2021‑0008
    [Google Scholar]
  22. El NabarawiM.A. TeaimaM.H. Abd El-MonemR.A. El NabarawyN.A. GaberD.A. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.Drug Des. Devel. Ther.2017111081109310.2147/DDDT.S13193628435220
    [Google Scholar]
  23. MunusamyR. ShanmugasundharamS. Enhanced gastric residence time of acyclovir by floating raft formulation using box-behnken design.Heliyon2024102e2430110.1016/j.heliyon.2024.e2430138293518
    [Google Scholar]
  24. VermaA. DubeyJ. VermaN. Kumar NayakA. Chitosan-hydroxypropyl methylcellulose matrices as carriers for hydrodynamically balanced capsules of moxifloxacin HCl.Curr. Drug Deliv.2017141839010.2174/156720181366616050410084227142106
    [Google Scholar]
  25. SoniS. RamV. VermaA. Crushed puffed rice-HPMC-chitosan based single-unit hydro-dynamically balanced system for the sustained stomach specific delivery of metoprolol succinate.J. Appl. Pharm. Sci.20177124757
    [Google Scholar]
  26. MuselíkJ. KomersováA. KubováK. MatzickK. SkalickáB. A critical overview of FDA and EMA statistical methods to compare in vitro drug dissolution profiles of pharmaceutical products.Pharmaceutics20211310170310.3390/pharmaceutics1310170334683995
    [Google Scholar]
  27. RuizM.E. VolontéM.G. Biopharmaceutical relevance of the comparison of dissolution profiles: Proposal of a combined approach.Dissolut. Technol.2014211324310.14227/DT210114P32
    [Google Scholar]
  28. RehmanS. JamilQ.A. NoreenS. Preparation and evaluation of pH-sensitive chitosan/alginate nanohybrid mucoadhesive hydrogel beads: An effective approach to a Gastro-retentive drug delivery system.Pharmaceutics20241611145110.3390/pharmaceutics1611145139598574
    [Google Scholar]
  29. SarfarazM.D. DhruvR.K. DoddayyaH. Ahmed KhanK.A. Factorial design based optimization of hydroxyzine hydrochloride fast dissolving tablets.Indian J. Pharm. Sci.202082578779810.36468/pharmaceutical‑sciences.707
    [Google Scholar]
  30. MaugerJohn.W. Physicochemical properties of buffers used in simulated biological fluids with potential application for in vitro dissolution testing: A mini-review.Dissolut. Technol.201724385110.14227/DT240317P38
    [Google Scholar]
  31. KathotaR. ModiC. ThakkarV. RanaH. PatelA. Development and characterization of febuxostat loaded floating beads as gastro-retentive drug delivery system in the treatment of gout: A statistical approach.Curr. Drug Ther.202318543344410.2174/1574885518666230331084428
    [Google Scholar]
  32. DeyA. SinghA. KurmiB.D. SinghD. A complete sojourn of current trends in Gastro-retentive drug delivery system: Recent advances and patent survey.Recent Pat. Nanotechnol.202418219020610.2174/187221051766623033108334637005511
    [Google Scholar]
  33. DhimanS. PhilipN. Gurjeet SinghT. An insight on novel approaches & perspectives for Gastro-retentive drug delivery systems.Curr. Drug Deliv.202320670872910.2174/156720181966622081920023635993477
    [Google Scholar]
  34. IglesiasN. GalbisE. Romero-AzogilL. In-depth study into polymeric materials in low-density gastroretentive formulations.Pharmaceutics202012763610.3390/pharmaceutics1207063632645909
    [Google Scholar]
  35. IbrahimM. NaguibY.W. SarhanH.A. AbdelkaderH. Preformulation-assisted design and characterization of modified release gastroretentive floating extrudates towards improved bioavailability and minimized side effects of baclofen.J. Pharm. Sci.202111031227123910.1016/j.xphs.2020.10.02533069710
    [Google Scholar]
  36. KotrekaU.K. AdeyeyeM.C. Gastroretentive floating drug-delivery systems: A critical review.Crit. Rev. Ther. Drug Carrier Syst.2011281479910.1615/CritRevTherDrugCarrierSyst.v28.i1.2021395515
    [Google Scholar]
  37. PathakK. AkhtarN. SinghS. Gastroretentive carrier systems in the delivery of therapeutic actives: An updated patent review.Pharm. Pat. Anal.20154645347410.4155/ppa.15.3426580994
    [Google Scholar]
  38. RazzaghiM. NavvabiA. HomaeeM.B. SaniR. MichaudP. HomaeiA. Exopolysaccharides in Drug Delivery Systems.In:Microbial Exopolysaccharides as Novel and Significant Biomaterials.ChamSpringer International Publishing2021143199
    [Google Scholar]
  39. KumarM. KaushikD. An overview on various approaches and recent patents on gastroretentive drug delivery systems.Recent Pat. Drug Deliv. Formul.2018122849210.2174/187221131266618030815021829521255
    [Google Scholar]
  40. LopesC.M. BettencourtC. RossiA. ButtiniF. BarataP. Overview on gastroretentive drug delivery systems for improving drug bioavailability.Int. J. Pharm.2016510114415810.1016/j.ijpharm.2016.05.01627173823
    [Google Scholar]
  41. MurphyC. PillayV. ChoonaraY. du ToitL. Gastroretentive drug delivery systems: Current developments in novel system design and evaluation.Curr. Drug Deliv.20096545146010.2174/15672010978994168719751198
    [Google Scholar]
  42. Abdul RasoolB.K. SammourR. DDSolver software application for quantitative analysis of in vitro drug release behavior of the gastroretentive floating tablets combined with radiological study in rabbits.Curr. Drug Deliv.202219994996510.2174/156720181966622030420301435249487
    [Google Scholar]
  43. BoontaweeR. IssarachotO. KaewkroekK. WiwattanapatapeeR. Foldable/expandable Gastro-retentive films based on starch and chitosan as a carrier for prolonged release of resveratrol.Curr. Pharm. Biotechnol.20222371009101810.2174/138920102266621061511555334132179
    [Google Scholar]
  44. AlzaherW. ShawJ. Al-KassasR. Gastroretentive formulations for improving oral bioavailability of drugs-focus on microspheres and their production.Curr. Drug Deliv.201613564666110.2174/156720181266615101211335726456212
    [Google Scholar]
  45. SalatinS. JelvehgariM. Expert design and optimization of ethyl cellulose-poly (-caprolactone) blend microparticles for Gastro-retentive floating delivery of metformin Hydrochloride.Curr. Drug Deliv.20211881125113533563167
    [Google Scholar]
  46. MamdouhM. DoniaA. EssaE. MaghrabyG.E. Preparation of liquid oral mucoadhesive Gastro-retentive system of nimodipine.Curr. Drug Deliv.201916986287110.2174/156720181666619101410253131633475
    [Google Scholar]
  47. DaihomB.A. BendasE.R. MohamedM.I. BadawiA.A. Domperidone resinate complex as new formulation for gastroretentive drug delivery.J. Drug Deliv. Sci. Technol.20205810186810186810.1016/j.jddst.2020.101868
    [Google Scholar]
  48. MathurP. JhawatV. DuttR. New insights into gastroretentive dosage forms in delivery of drugs.Curr. Nanomed.20211129110110.2174/2468187311666210603121313
    [Google Scholar]
  49. SabaleV. ChaudhariH. SabaleP. Formulation and in vitro evaluation of gastroretentive floating bioadhesive tablets of Nizatidine using factorial design.Drug Deliv. Lett.20199323423910.2174/2210303109666190221155353
    [Google Scholar]
  50. LeggioL. GarbuttJ. AddoloratoG. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients.CNS Neurol. Disord. Drug Targ201091334410.2174/18715271079096661420201813
    [Google Scholar]
  51. JainS. NamdevA. JainD. Dual component tablets for the treatment of gastroesophageal reflux disease.Drug Deliv. Lett.201991697810.2174/2210303108666181010110215
    [Google Scholar]
/content/journals/caps/10.2174/0124522716362601250212100844
Loading
/content/journals/caps/10.2174/0124522716362601250212100844
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test